Testing a new lice shampoo for kids and adults
Part of Infections clinical trials.
This trial tests a new medical shampoo to treat head lice. It might be an option for people with mild to moderate lice and various hair types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old (or 3 for certain study groups).
- You have a mild to moderate lice infestation (fewer than 25 live lice).
- Your hair is short to mid-length (not past your shoulders) and straight to curly (types 1 to 3C).
- You or your legal guardian understand the study and sign a consent form.
- Women who could become pregnant must use birth control for at least 4 weeks before and during the study.
- You have not used any anti-lice treatment in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-chemical lice treatment (a liquid) against a standard anti-lice shampoo. It is for people with mild to moderate head lice who want a safe, effective option without harsh chemicals.
This trial tests a new head lice product (X92001483) to see how safe and effective it is compared to the standard treatment Nix. It looks at both getting rid of lice and preventing them from coming back.
This study compares a new lice lotion to a standard lice shampoo to see how well they work and if they are safe. If you or your child has head lice, participating could help find a better way to get rid of them.
This study tests a new antidandruff lotion designed to restore the natural balance of microbes on your scalp. If you have moderate to severe dandruff and are generally healthy, this trial may help improve your dandruff with a specially formulated product.
This study tests two new oral medicines compared to an existing oral medicine for people with a first episode of cutaneous leishmaniasis (skin sores caused by a parasite). It aims to find a more effective and convenient treatment.
This study tests a new medication called nemolizumab for people with lichen planopilaris (LPP), a type of scarring hair loss. It aims to see if the drug can help reduce scalp itching and improve the condition.
Hear when a new Headlice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.